BHVN

Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical innovator with a focus on developing groundbreaking therapies for neurological diseases and rare disorders. Based in New Haven, Connecticut, the company leverages its cutting-edge research and development capabilities to advance its portfolio of candidate products, aiming to address unmet medical needs in the U.S. market. With a commitment to scientific excellence and patient-centric solutions, Biohaven is positioned to make significant contributions to the treatment landscape of challenging health conditions.